We use cookies for a better user experience. Read our Privacy Policy

I Agree

Ambulatory Cardiac Monitoring Devices Market

Ambulatory Cardiac Monitoring Devices Market (Type: ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Heart Patients Demanding Advanced Cardiac Monitoring Devices

Ambulatory cardiac monitors are small, movable electrocardiograph machines that can record the heart’s rhythm. The features in such monitors vary based on the length of recording time and the ability to send the recordings over the phone. Most professional experts use ambulatory cardiac monitors to assess heartbeat rate over time, correlate symptoms with the heartbeat, diagnose abnormal heart rhythms, and analyze other symptoms a heart can have. These devices help monitor the heart with increased detection time and with more precise results as compared to conventional heart monitors. This is likely to boost the global ambulatory cardiac monitoring devices market during the forecast period.

In simpler terms, ambulatory cardiac monitoring devices are used to assist doctors to diagnose irregular cardiac arrhythmias that occur only sporadically and unpredictably. Such arrhythmias often exhibit sudden symptoms, but usually are not present by the time the patient gets to a doctor. For this reason, many symptom-producing cardiac arrhythmias are challenging or unlikely to diagnose with conventional ECGs. Ambulatory cardiac monitoring devices have proven useful to monitor and record the heartbeats for longer spans to capture a brief, irregular, but potentially vital arrhythmia. The growing number of heart-related cases across the world owing to factors such as increasing obesity, diabetes mellitus, smoking, high cholesterol, high blood pressure, and sedentary lifestyles, are expected to be major factors driving the global ambulatory cardiac monitoring devices market.

ambulatory cardiac monitoring devices market infographic

Request a sample to get extensive insights into the Ambulatory Cardiac Monitoring Devices Market

Cardiac Patients at Greater Risks amid COVID-19 Crisis

COVID-19 has posed various kinds of challenges for doctors whose cardiac patients are at-risk and hesitant to schedule a visit. People with cardiac issues are concerned about coronavirus, but in their caution, they can die from an unmonitored, untreated cardiac condition. Besides, the number of deaths from cardiac diseases is more than that of COVID-19 patients. However, at a time when cardiac monitoring is more critically important than ever, patients may have greater hesitation to visit a hospital. Moreover, people in rural areas face more challenges of having to travel to the doctor, as they might not have at least one cardiologist nearby. Interns and practitioners are being trained to use cardiac monitoring devices in case of emergencies. This has propelled the ambulatory cardiac monitoring devices market. However, stringent regulations for travel, manufacturing, supply chain, and trade to limit the virus have impacted the production and distribution of such devices.

There has been a notable decrease in admissions for cardiac arrests and failure, owing to the threat coronavirus poses on heart patients. Moreover, there is accumulating evidence to suggest COVD-19 has vital and even long-term cardiac effects, which may lead to a series of heart failure patients leading to a new crisis. Thus, the demand for the use of ambulatory cardiac monitoring devices is hindered during this time. However, with the growing number of vaccinations in various nations and innovation in medicines and drugs, the global ambulatory cardiac monitoring devices market is expected to surge post-COVID-19.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Growing Need for Innovative Technology in Heart-related Issues Fuel Global Market

The most advanced and minimally invasive surgery utilization to improve patients' heart activity and intensify the outcomes of various cardiac procedures is one of the key factors propelling the growth of the ambulatory cardiac monitoring devices market. Moreover, the rising demand for advanced cardiac devices, such as Holter monitors, event monitors, implantable loop recorders, mobile cardiac telemetry helping the future ambulatory cardiac monitoring devices market growth. Furthermore, rising government and people investment in healthcare and favorable reimbursement policies are among the major factors expanding the ambulatory cardiac monitoring devices market.

ambulatory cardiac monitoring devices market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Ambulatory Cardiac Monitoring Devices Market

Analysts’ Viewpoint

The global medical data suggests that one out of 10 people suffers from heart-related issues, including coronary heart disease, angina, high and low blood pressure, heart attack, arrhythmia, and valve blockage. Thus, ambulatory cardiac monitoring devices have become necessary to track and monitor the heart to avoid fatal outcomes of such diseases. Cardiac monitoring is also crucial in the administration of heart attacks, the value of cardiac output, and for monitoring of sepsis cases. Ambulatory cardiac monitoring devices are also used to detect, eliminate, and restrict mycoplasma infection in cell culture, making them fit for use in research institutions and organizations. The growing concerns of heart patients and an increasing number of such patients are driving the ambulatory cardiac monitoring devices market.

Ambulatory Cardiac Monitoring Devices Market: Overview

  • The global ambulatory cardiac monitoring devices market was valued at US$ 13.5 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031. Rise in demand for prolonged ECG monitoring & self-care management and increase in burden of cardiovascular diseases drive the need of ambulatory cardiac monitoring devices. Key industry developments, including partnerships, mergers & acquisitions, and collaborations, are anticipated to fuel the growth of the global ambulatory cardiac monitoring devices market.
  • Obesity, diabetes mellitus, smoking, high cholesterol, high blood pressure, and sedentary lifestyles are the leading causes of heart failure. Rise in number of people afflicted by these diseases is expected to increase the demand for ambulatory cardiac monitoring devices.
  • According to the American Heart Association’s 2017 Heart Diseases and Stroke Statistics update, the number of people diagnosed with heart failure is increasing and projected to rise by 46% by 2030, resulting in over 8 million people with heart failure. Around 22 million people are living with congestive heart failure globally, with 2 million people diagnosed every year. According to the American Heart Association, congestive heart failure is one of the leading causes of death in the U.S., accounting for 8.5% of the deaths.
  • According to the World Journal of Cardiovascular Diseases, over 7 million deaths occur due to sudden cardiac arrest globally every year. Sudden cardiac arrest accounts for about 20% of all mortalities in the West.
  • Utilization of implantable cardiac monitors has increased to keep track of irregularity of the heart rhythm compared to Holter and other external patch. Insertable cardiac monitors (ICMs, or implantable loop recorders, ILRs) are small subcutaneous devices that continuously monitor the heart rhythm and record events for several years.
  • Insertable cardiac monitors are commonly used to monitor patients with syncope or stroke of unknown origin for infrequent rhythm abnormalities, as well as for long-term monitoring of atrial fibrillation post ablation. ICMs i.e., insertable cardiac monitors, are small, subcutaneously implanted devices offering continuous ambulatory electrocardiogram (ECG) monitoring with a lifespan of up to three years.

Ambulatory Cardiac Monitoring Devices Market: Segmentation

  • The global ambulatory cardiac monitoring devices market has been segmented based on type and region
  • In terms of type, the global ambulatory cardiac monitoring devices market has been classified into ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry. ECG devices have been bifurcated into resting ECG devices and stress ECG devices.
  • The ECG devices segment captured the largest market share in 2020 and the trend is likely to continue during the forecast period. Government support is a major factor driving the ECG devices segment in Singapore. Export and usage of medical equipment are rising due to expansion of the domestic market and foreign investments.

Ambulatory Cardiac Monitoring Devices Market: Regional Segmentation

  • In terms of region, the global ambulatory cardiac monitoring devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to be a highly attractive market from 2021 to 2031. Significant revenue from the region can be attributed to increase in government and private funding and large volume of tests for cardiac diseases performed. Moreover, high prevalence of heart failure due to aging population and changes in dietary habits is anticipated to drive the ambulatory cardiac monitoring devices market in North America.
  • The ambulatory cardiac monitoring devices market in Asia Pacific is expected to be driven by high adoption of ambulatory cardiac monitoring devices. According to a study published in the Radcliffe Cardiology journal, heart failure is a major health problem in Asia Pacific and its prevalence seems to be higher than countries in the West. Rise in awareness about heart failure and risk of sudden cardiac arrest associated with this condition propels the market in the region.

Ambulatory Cardiac Monitoring Devices Market: Major Players

  • Key players operating in the global ambulatory cardiac monitoring devices market are
    • Abbott
    • Boston Scientific Corporation
    • GE Healthcare
    • Hill-Rom Holdings
    • Koninklijke Philips N.V.
    • Medtronic
    • Nihon Kohden Corporation
    • Asahi Kasei Medical Co., Ltd.
  • These players focus on adopting various strategies to expand product offerings and to strengthen geographic presence across the globe. Technological advancements, mergers & acquisition, expansion of product portfolio, and rise in research & development are strategies adopted by companies to expand market presence.

Ambulatory Cardiac Monitoring Devices Market – Segmentation

Type
  • ECG Devices
    • Resting ECG Devices
    • Stress ECG Devices
  • Holter Monitors
  • Event Monitors
  • Implantable Loop Recorders
  • Mobile Cardiac Telemetry
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Ambulatory Cardiac Monitoring Devices Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of ambulatory cardiac monitoring devices market?

Ambulatory cardiac monitoring devices market to cross valuation of US$29 Bn by 2031

What are the key driving factors for the growth of the ambulatory cardiac monitoring devices market?

Ambulatory cardiac monitoring devices market is driven by rise in demand for prolonged ECG monitoring & self-care management and increase in burden of cardiovascular diseases

Which region is expected to project the highest market share in the global ambulatory cardiac monitoring devices market?

North America accounted for a major share of the global ambulatory cardiac monitoring devices market

Which is the rising prominent segment in the ambulatory cardiac monitoring devices market?

The ECG devices segment captured the largest market share in 2020 and the trend is likely to continue during the forecast period

Who are the key players in the global ambulatory cardiac monitoring devices market?

Key players operating in the global ambulatory cardiac monitoring devices market are Abbott, Boston Scientific Corporation, GE Healthcare, Hill-Rom Holdings, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, Asahi Kasei Medical Co., Ltd.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ambulatory Cardiac Monitoring Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Prevalence of Heart Failure

    5.2. Brand Analysis

    5.3. Patient Pathway for Ambulatory Cardiac Monitoring

    5.4. Value Chain Analysis

    5.5. Pricing Analysis

    5.6. Reimbursement Scenario

    5.7. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Type, 2017–2031

        6.3.1. ECG Devices

            6.3.1.1. Resting ECG Devices

            6.3.1.2. Stress ECG Devices

        6.3.2. Holter Monitors

        6.3.3. Event Monitors

        6.3.4. Implantable Loop Recorders

        6.3.5. Mobile Cardiac Telemetry

    6.4. Market Attractiveness Analysis, by Type 

7. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, by Region

    7.1. Key Findings

    7.2. Market Value Forecast, by Region

        7.2.1. North America 

        7.2.2. Europe 

        7.2.3. Asia Pacific 

        7.2.4. Latin America 

        7.2.5. Middle East & Africa 

    7.3. Market Attractiveness Analysis, by Country/Region

8. North America Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

    8.2. Market Value Forecast, by Type, 2017–2031

        8.2.1. ECG Devices

            8.2.1.1. Resting ECG Devices

            8.2.1.2. Stress ECG Devices

        8.2.2. Holter Monitors

        8.2.3. Event Monitors

        8.2.4. Implantable Loop Recorders

        8.2.5. Mobile Cardiac Telemetry

    8.3. Market Value Forecast, by Country, 2017–2031

        8.3.1. U.S.

        8.3.2. Canada

    8.4. Market Attractiveness Analysis 

        8.4.1. By Type 

        8.4.2. By Country

9. Europe Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Type, 2017–2031

        9.2.1. ECG Devices

            9.2.1.1. Resting ECG Devices

            9.2.1.2. Stress ECG Devices

        9.2.2. Holter Monitors

        9.2.3. Event Monitors

        9.2.4. Implantable Loop Recorders

        9.2.5. Mobile Cardiac Telemetry

    9.3. Market Value Forecast, by Country/Sub-region, 2017–2031

        9.3.1. Germany

        9.3.2. U.K.

        9.3.3. France

        9.3.4. Spain

        9.3.5. Italy

        9.3.6. Rest of Europe

    9.4. Market Attractiveness Analysis 

        9.4.1. By Type 

        9.4.2. By Country/Sub-region

10. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Type, 2017–2031

        10.2.1. ECG Devices

            10.2.1.1. Resting ECG Devices

            10.2.1.2. Stress ECG Devices

        10.2.2. Holter Monitors

        10.2.3. Event Monitors

        10.2.4. Implantable Loop Recorders

        10.2.5. Mobile Cardiac Telemetry

    10.3. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.3.1. China

        10.3.2. Japan

        10.3.3. India

        10.3.4. Australia & New Zealand

        10.3.5. Rest of Asia Pacific

    10.4. Market Attractiveness Analysis 

        10.4.1. By Type 

        10.4.2. By Country/Sub-region

11. Latin America Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Type, 2017–2031

        11.2.1. ECG Devices

            11.2.1.1. Resting ECG Devices

            11.2.1.2. Stress ECG Devices

        11.2.2. Holter Monitors

        11.2.3. Event Monitors

        11.2.4. Implantable Loop Recorders

        11.2.5. Mobile Cardiac Telemetry

    11.3. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.3.1. Brazil

        11.3.2. Mexico

        11.3.3. Rest of Latin America

    11.4. Market Attractiveness Analysis 

        11.4.1. By Type 

        11.4.2. By Country/Sub-region

12. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Type, 2017–2031

        12.2.1. ECG Devices

            12.2.1.1. Resting ECG Devices

            12.2.1.2. Stress ECG Devices

        12.2.2. Holter Monitors

        12.2.3. Event Monitors

        12.2.4. Implantable Loop Recorders

        12.2.5. Mobile Cardiac Telemetry

    12.3. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.3.1. GCC Countries

        12.3.2. South Africa

        12.3.3. Rest of Middle East & Africa

    12.4. Market Attractiveness Analysis 

        12.4.1. By Type 

        12.4.2. By Country/Sub-region

13. Competition Landscape

    13.1. Market Share Analysis, by Company, 2020

    13.2. Company Profiles

        13.2.1. Abbott

            13.2.1.1. Company Overview

            13.2.1.2. Company Financials

            13.2.1.3. Growth Strategies

            13.2.1.4. SWOT Analysis

        13.2.2. Boston Scientific Corporation

            13.2.2.1. Company Overview

            13.2.2.2. Company Financials

            13.2.2.3. Growth Strategies

            13.2.2.4. SWOT Analysis

        13.2.3. GE Healthcare

            13.2.3.1. Company Overview

            13.2.3.2. Company Financials

            13.2.3.3. Growth Strategies

            13.2.3.4. SWOT Analysis

        13.2.4. Hill-Rom Holdings

            13.2.4.1. Company Overview

            13.2.4.2. Company Financials

            13.2.4.3. Growth Strategies

            13.2.4.4. SWOT Analysis

        13.2.5. Koninklijke Philips N.V.

            13.2.5.1. Company Overview

            13.2.5.2. Company Financials

            13.2.5.3. Growth Strategies

            13.2.5.4. SWOT Analysis

        13.2.6. Medtronic

            13.2.6.1. Company Overview

            13.2.6.2. Company Financials

            13.2.6.3. Growth Strategies

            13.2.6.4. SWOT Analysis

        13.2.7. Nihon Kohden Corporation

            13.2.7.1. Company Overview

            13.2.7.2. Company Financials

            13.2.7.3. Growth Strategies

            13.2.7.4. SWOT Analysis

        13.2.8. Asahi Kasei Medical Co., Ltd.

            13.2.8.1. Company Overview

            13.2.8.2. Company Financials

            13.2.8.3. Growth Strategies

            13.2.8.4. SWOT Analysis

List of Tables

Table 01: Global Stroke Incident Cases

Table 02: Global Prevalence of Heart Failure (2017)

Table 03: Status of Cardiac Surgeries in Countries in South Asia 2016–2017

Table 04: Status of Cardiac Surgeries in North America 

Table 05: New Zealand all cardiac surgery patients in 2016: age and gender

Table 06: Europe Hospital discharge rates for in-patients with diseases of the cardiovascular system, 2016-2017

Table 07: Key Product/Brand Analysis of Implantable Loop Recorder

Table 08: Key Product/Brand Analysis of Holter Monitors

Table 09: Key Product/Brand Analysis of ECG

Table 10: Key Product/Brand Analysis of Event Monitors

Table 11: Key Product/Brand Analysis of Event Monitors

Table 12: Key Product/Brand Analysis of Mobile Cardiac Telemetry

Table 13: Ambulatory Cardiac Monitoring Devices Procedures performed till 2018

Table 14: Ambulatory Cardiac Monitoring Devices Procedures performed after January 2019

Table 15: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 16: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

Table 17: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 18: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 19: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 20: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

Table 21: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 23: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

Table 24: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 25: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 26: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

Table 27: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 28: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 29: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

Table 30: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 31: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 32: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

Table 33: GE Healthcare Business Overview

Table 34: Koninklijke Philips N.V. Business Overview

Table 35: Medtronic plc Business Overview

Table 36: Abbott Laboratories Business Overview

Table 37: Boston Scientific Corporation Business Overview

Table 38: Hill-Rom Holdings, Inc. Business Overview

Table 39: Nihon Kohden Corporation Business Overview

Table 40: Asahi Kasei Medical Co., Ltd. Business Overview

List of Figures

Figure 01: Global Ambulatory Cardiac Monitoring Devices Market Share, by Type

Figure 02: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031

Figure 03: Procedures performed in 2017 (New Zealand)

Figure 04: Procedures performed in 2017 (Australia)

Figure 05: Value Chain Analysis

Figure 06: Global Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

Figure 07: Global Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

Figure 08: Global Ambulatory Cardiac Monitoring Devices Market Analysis, by Region

Figure 09: Global Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Region, 2020 and 2031

Figure 10: Global Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Region, 2021–2031

Figure 11: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

Figure 12: North America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country, 2020 and 2031

Figure 13: North America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country, 2021–2031

Figure 14: North America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

Figure 15: North America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

Figure 16: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

Figure 17: Europe Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 18: Europe Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 19: Europe Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

Figure 20: Europe Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

Figure 21: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

Figure 22: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 23: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 24: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

Figure 25: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

Figure 26: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

Figure 27: Latin America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 28: Latin America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 29: Latin America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

Figure 30: Latin America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

Figure 31: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

Figure 32: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 33: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 34: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

Figure 35: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

Figure 36: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 37: GE Healthcare Breakdown of Net Sales (%), by Region/Country, 2019

Figure 38: GE Healthcare Breakdown of Net Sales (%), by Business Segment, 2019

Figure 39: GE Healthcare R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 40: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 41: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region/Country, 2019

Figure 42: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2019

Figure 43: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 44: Medtronic plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 45: Medtronic plc Breakdown of Net Sales (%), by Region/Country, 2020

Figure 46: Medtronic plc Breakdown of Net Sales (%), by Business Segment, 2020

Figure 47: Medtronic plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 48: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 49: Abbott Laboratories Breakdown of Net Sales (%), by Region/Country, 2019

Figure 50: Abbott Laboratories Breakdown of Net Sales (%), by Business Segment, 2019

Figure 51: Abbott Laboratories R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 52: Boston Scientific Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 53: Boston Scientific Corporation Breakdown of Net Sales (%), by Region/Country, 2019

Figure 54: Boston Scientific Corporation Breakdown of Net Sales (%), by Business Segment, 2019

Figure 55: Boston Scientific Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 56: Hill-Rom Holdings, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 57: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Region/Country, 2020

Figure 58: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Business Segment, 2020

Figure 59: Hill-Rom Holdings, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 60: Nihon Kohden Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 61: Nihon Kohden Corporation Breakdown of Net Sales (%), by Region/Country, 2019

Figure 62: Nihon Kohden Corporation Breakdown of Net Sales (%), by Business Segment, 2019

Figure 63: Nihon Kohden Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 64: Asahi Kasei Medical Co., Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 65: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Region/Country, 2019

Figure 66: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Business Segment, 2019

Figure 67: Asahi Kasei Medical Co., Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

552

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved